Targovax has announced that the first patient has been dosed with cancer vaccine TG01 in the combination study with PD-1 checkpoint inhibitor (CPI) balstilimab in mutant RAS pancreatic cancer in the USA.
The study is led by gastrointestinal cancer expert Dr. Anup Kasi in a three-way clinical coll